氯化钴,六水

氯化钴,六水用途

1.用于电镀。用作玻璃和陶瓷着色剂、油漆催干剂、氨的吸收剂。制造钴催化剂，制造变色硅胶干湿指示剂。制造隐显墨水。用作啤酒泡沫稳定剂。畜牧业配制复合饲料，作为钴的补充剂。 2.用作分析试剂，适度及水分指示剂，氨吸收剂。用于培养基配制，催化剂制备。还用于电镀。
3.用作饲料营养强化剂。钴参与维生素B12的合成，有激活生物酶，抗再生障碍性贫血的作用。氯化钴作为钴的补充剂，在畜牧业中用于配置复合饲料。 4. 畜牧业中用于配置复合饲料，作为钴的补充剂。仪器制造中用于生产气压计、比重计、干湿指示剂等。陶瓷工业用作着色剂。涂料工业用于制造涂料催干剂。酿造工业用作啤酒泡沫稳定剂。国防工业用于制造毒气罩。化学反应中用作催化剂。分析化学中用于点滴分析锌、单倍体育种。此外，还用于制造隐显墨水、氯化钴试纸、变色硅胶等。还用作氨的吸收剂。 5. 用于镀锡钴合金和钴镍磷合金电解液中，也可用作镀锌的添加剂、化学镀钴及钴合金等。

氯化钴,六水名称

[ CAS 号 ]:
7791-13-1

[ 中文名 ]:
六水氯化钴

[ 英文名 ]:
Cobalt(II)chloridehexahydrate

[中文别名 ]:

[英文别名 ]:

Dichlorocobalt hexahydrate
MFCD00149652
Cobalt chloride hexa
CobaltousChlorideAr
CobaltChloride6H2OAcs
COBALTOUS CHLORIDE 6H2O
COBALT CHLORIDE PURPUREO
Cobalt chloride hexahydrate
COBALTOUS CHLORIDE
EINECS 231-589-4

氯化钴,六水物理化学性质

[ 密度 ]:
3.35

[ 沸点 ]:
1049 °C

[ 熔点 ]:
86 °C

[ 分子式 ]:
H₁₂Cl₂CoO₆

[ 分子量 ]:
237.931

[ 精确质量 ]:
236.934296

[ PSA ]:
55.38000

[ 外观性状 ]:
蓝色结晶粉末

[ 蒸汽压 ]:
40 mm Hg ( 0 °C)

[ 储存条件 ]:
库房低温,通风,干燥

氯化钴,六水MSDS

详细MSDS(安全技术说明书)

氯化钴,六水毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: GG0200000

CHEMICAL NAME :: Cobalt(II) chloride, hexahydrate

CAS REGISTRY NUMBER :: 7791-13-1

LAST UPDATED :: 199801

DATA ITEMS CITED :: 22

MOLECULAR FORMULA :: Cl2-Co.6H2-O

MOLECULAR WEIGHT :: 237.95

WISWESSER LINE NOTATION :: CO G2 &QH 6

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 766 mg/kg

TOXIC EFFECTS :: Behavioral - tremor Gastrointestinal - hypermotility, diarrhea Nutritional and Gross Metabolic - weight loss or decreased weight gain

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 35 mg/kg

TOXIC EFFECTS :: Cardiac - other changes Skin and Appendages - dermatitis, other (after systemic exposure)

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 121 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 90 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 100 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 30300 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 200 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 25400 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 26 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 120 mg/kg/2D-I

TOXIC EFFECTS :: Liver - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other oxidoreductases

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 3949 mg/kg

SEX/DURATION :: male 13 week(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Paternal Effects - other effects on male

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 182 mg/kg

SEX/DURATION :: male 13 week(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 143 mg/kg

SEX/DURATION :: male 3 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 1932 mg/kg

SEX/DURATION :: male 12 week(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Paternal Effects - other effects on male Endocrine - androgenic

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 6056 mg/kg

SEX/DURATION :: male 12 week(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

DOSE :: 47590 mg/kg

SEX/DURATION :: female 8 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - musculoskeletal system

MUTATION DATA

TYPE OF TEST :: Mutation in mammalian somatic cells

TEST SYSTEM :: Rodent - mouse Mammary gland

DOSE/DURATION :: 2 umol/L

REFERENCE :: MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 261,131,1991 *** REVIEWS *** IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 52,363,1991 IARC Cancer Review:Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 52,363,1991 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4499 No. of Facilities: 96 (estimated) No. of Industries: 2 No. of Occupations: 2 No. of Employees: 346 (estimated) No. of Female Employees: 34 (estimated)

氯化钴,六水安全信息

[ 符号 ]:

GHS07, GHS08, GHS09

[ 信号词 ]:
Danger

[ 危害声明 ]:
H302-H317-H334-H341-H350i-H360F-H410

[ 警示性声明 ]:
P201-P261-P273-P280-P284-P304 + P340

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
T:Toxic

[ 风险声明 (欧洲) ]:
R22;R42/43;R49;R50/53

[ 安全声明 (欧洲) ]:
S53-S22-S45-S60-S61

[ 危险品运输编码 ]:
UN 3260 8/PG 2

[ WGK德国 ]:
2

[ RTECS号 ]:
GG0200000

[ 包装等级 ]:
III

[ 危险类别 ]:
9.0

[ 海关编码 ]:
28273400

氯化钴,六水制备

1.金属钴法将盐酸加人反应器中，再逐渐加入金属钴，使其溶解并加热至80℃进行反应，并视金属钴溶解情况适当地加入硝酸，把生成的氯化钴溶液用过氧化氢净化除铁，必要时加入碳酸钠或氨水调节，以保证净化完全。经净化后的氯化钴溶液用盐酸调节至Ph2～3。经过滤、蒸发至沸腾、冷却结晶、离心分离、干燥，制得氯化钴成品。其反应方程式如下：

2.含钴废料法将各种含钴废料(下脚料)，经硝酸、盐酸、硫酸溶解，加人硫化钠转化成NiS·CoS。经通入空气氧化得到NiS()4·(30S()4，加人烧碱，通入氯气，分离得到氢氧化钴和硫酸镍溶液，将氢氧化钴加入盐酸进行反应生成氯化钴，过滤后水洗，得到粗制氯化钻，加入过氧化氢精制，再经蒸发浓缩、冷却结晶、离心分离、干燥，制得氯化钴成品。其反应方程式如下：

3.氯化钴的生产采用金属钴法和含钴废料法。工业上一般采用金属加工和以电子工业的含钴废料为原料，用混酸（盐酸和硝酸）溶解而得。
将盐酸加入反应器，再投入含钴废料于80℃下进行反应，并视金属钴溶解情况适当加入硝酸。氯化钴溶液用过氧化氢净化除铁，如溶液PH<5，则加入碳酸钠或氨水，以保证净化完全。净化后的氯化钴溶液用演算调节PH至2-3，经过滤、蒸发、结晶、分离得成品 4.三氧化二钴与盐酸反应生成氯化钴。在1L分析纯的浓盐酸(比重为119)中加入400mL水，在搅拌下慢慢加入120g Co2O3(无镍试剂)，将混合物放在水浴上加热，并分多次慢慢再加入230g Co2O3。将所得溶液过滤，向滤液中加入10mL HCl后进行蒸发浓缩，直至溶液表面有较厚的结晶膜时开始冷却。将析出的氯化钴结晶弄碎后用100mL水洗涤，在布氏漏斗上抽干，最后摊平在玻璃板上于35～45℃的温度下干燥，直至成为干燥松散的结晶为止。 5. 将份工业品六水合氯化钴和1份工业品氯化铵溶解在4份水中，加入3份相对密度为0.91的氢氧化铵，并往溶液中通入空气6～8h然后加入1份碳酸铵，溶解后重新通入空气6～8h，再将溶液慢慢加热至90℃。将溶液蒸发，添加相对密度为1.19的盐酸至石蕊呈强酸性，重新蒸发，静置过夜，析出物过滤，用分析纯稀盐酸（1∶ 4）洗涤2次，于30～45℃干燥10～12h，得分析纯成品。母液回收利用也可制取分析纯成品。母液回收利用也可制取分析纯成品。 6. 将金属钴和水加入反应器中，加热至60～70℃，再逐渐加入相对密度为1.40工业硝酸使其溶解并反应：反应结束后，加入碳酸钴调节溶液至中性并沉淀出铁。然后加热至60～70℃，保温2～3h，过滤后用等体积水稀释。将热的稀释液在不断搅拌下缓缓加到2%～5%的热氢氧化铵溶液中，至ph＝9～10，分出母液，往沉淀中加2%～5%的氢氧化铵和硝酸钴（二者量相同），分出母液（重复四遍）。将沉淀倾析洗涤2～3次，过滤，用水洗至中性，迅速沉淀并过滤。将相对密度为1.19的盐酸加到上述新鲜氢氧化钴溶液中进行反应：过滤后，蒸发溶液至相对密度为1.46～1.47，冷却结晶，用少量水洗涤，滤干，于35～45℃下干燥，即得成品六水合氯化钴。

氯化钴,六水海关

[ 海关编码 ]: 28273400

氯化钴,六水文献

Nematic liquid crystals confined in microcapillaries for imaging phenomena at liquid-liquid interfaces.

Soft Matter 11 , 6999-7004, (2015)

Here, we report the development of an experimental system based on liquid crystals (LCs) confined in microcapillaries for imaging interfacial phenomena. The inner surfaces of the microcapillaries were...

Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes.

Biomaterials 57 , 1-11, (2015)

Antibody-mediated targeting therapy has been successful in treating patients with cancers by improving the specificity and clinical efficacy. In this study, we developed a human epidermal growth facto...

Highly sensitive SERS-based immunoassay of aflatoxin B1 using silica-encapsulated hollow gold nanoparticles.

J. Hazard. Mater. 285 , 11-7, (2015)

Aflatoxin B1 (AFB1) is a well-known carcinogenic contaminant in foods. It is classified as an extremely hazardous compound because of its potential toxicity to the human nervous system. AFB1 has also ...

更多文献